Volume 2 Number 3 November 2006

Editorial

• Serruys PW

EuroInterv.2006;2:273-275

Everolimus eluting stents: beyond targeting restenosis!

• Finn AV,
• Nakazawa G,
• Joner M,
• Virmani R

EuroInterv.2006;2:277-279

What is the outcome of mother and child after percutaneous mitral valvuloplasty performed during pregnancy?

• Roos-Hesslink J

EuroInterv.2006;2:280-281

You ain't seen nothing yet...

• Meier B

EuroInterv.2006;2:282-283

European Association of Percutaneous Cardiovascular Interventions (EAPCI)

• Wijns W

EuroInterv.2006;2:284-285

A randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent: the SPIRIT II trial

• Serruys PW,
• Ruygrok P,
• Neuzner J,
• Piek J,
• Seth A,
• Schofer J,
• Richardt G,
• Wiemer M,
• Carrié D,
• Thuesen L,
• Boone E,
• Miquel-Herbert K,
• Daemen J

EuroInterv.2006;2:286-294

The randomised study of the double dose versus single dose sirolimus-eluting stent for the treatment of diabetic patients with de novo coronary lesions

• Costa RA,
• Eduardo Sousa J,
• Abizaid A,
• Chaves A,
• Feres F,
• Sousa A,
• Musumeci G,
• Mehran R,
• Fitzgerald P,
• Lansky AJ,
• Leon M,
• Shiran A,
• Halon D,
• Lewis B,
• Guagliumi G

EuroInterv.2006;2:295-301

Long term outcome of balloon mitral commissurotomy during pregnancy: a prospective physical and mental evaluation of babies

• Gamra H,
• Ben-Farhat M,
• Betbout F,
• Addad F,
• Ben-Rejeb R,
• Dridi Z,
• Khedher S,
• Ben-Hamda K,
• Maatouk F,
• Maaoui S

EuroInterv.2006;2:302-309

Biodegradable-Polymer-Based, Paclitaxel-Eluting Infinnium™ Stent: 9-Month clinical and angiographic follow-up results from the SIMPLE II prospective multi-centre registry study

• Vranckx P,
• Serruys PW,
• Gambhir S,
• Eduardo Sousa J,
• Abizaid A,
• Lemos P,
• Ribeiro E,
• Dani S,
• Dalal JJ,
• Mehan V,
• Dhar A,
• Dutta AL,
• Reddy KN,
• Chand R,
• Ray A,
• Symons J

EuroInterv.2006;2:310-317

Catheter closure of paravalvular leak

• Hein R,
• Wunderlich N,
• Robertson G,
• Wilson N,
• Sievert H

EuroInterv.2006;2:318-325

Percutaneous Patent Foramen Ovale (PFO) closure in young patients with both cryptogenic brain infarction and PFO associated with Atrial Septal Aneurysm (ASA)

• Juliard J-M,
• Abboud H,
• Aubry P,
• Brochet E,
• Sauguet A,
• Depoix J-P,
• Philip Y,
• Messika-Zeitoun D,
• Lung B,
• Vahanian A,
• Amarenco P

EuroInterv.2006;2:326-329

Two-year clinical follow-up of the unrestricted use of the paclitaxel-eluting stent compared to the sirolimus-eluting stent as part of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry

• Daemen J,
• Tsuchida K,
• Stefanini GG,
• Vaina S,
• Kukreja N,
• de Jaegere P,
• Ong ATL,
• van Domburg R,
• Serruys PW

EuroInterv.2006;2:330-337

Virtual histology and remodelling index allow in vivo identification of allegedly high-risk coronary plaques in patients with acute coronary syndromes: a three vessel intravascular ultrasound radiofrequency data analysis

• García-García HM,
• Goedhart D,
• Schuurbiers JCH,
• Kukreja N,
• Tanimoto S,
• Daemen J,
• Morel M-A,
• Bressers M,
• Van Es G-A,
• Wentzel J,
• Gijsen F,
• van der Steen A,
• Serruys PW

EuroInterv.2006;2:338-344

Human myocardium preconditioning during successive balloon inflations: irrelevant influence of both collateral recruitment and clinical pre-intervention interference

• Pimentel WA,
• Ambrose J,
• Mathias W,
• Arruda A,
• Horta P,
• Ribeiro E,
• Esteves-Filho A,
• Lemos P,
• Ramires J

EuroInterv.2006;2:345-350

Incidence of procedural related myocardial infarction following percutaneous coronary intervention.

• Wiseth R,
• Hegbom K,
• Slette M,
• Asberg A,
• Vik-Mo H

EuroInterv.2006;2:351-355

Sirolimus-Eluting Stents vs Bare Metal Stents for the treatment of unprotected left main coronary artery stenosis

• Sheiban I,
• Meliga E,
• Moretti C,
• Fumagalli A,
• Omedè P,
• Sciuto F,
• Grossomarra W,
• Trevi GP

EuroInterv.2006;2:356-362

Coronary perforations

• Nair P,
• Roguin A

EuroInterv.2006;2:363-370

What is the role for revascularisation in patients being considered for ICD therapy?

• Paisey JR,
• Morgan JM,
• Curzen N

EuroInterv.2006;2:371-374

The how and why of... Chronic Total Occlusions - Part One: How to treat CTOs

• Mitsudo K

EuroInterv.2006;2:375-381

The how and why of... Chronic Total Occlusions - Part Two: Why we treat CTOs the way we do

• Hoye A

EuroInterv.2006;2:382-388

Contrast enhancement of coronary arteries in cardiac surgery: a new multispectral stereoscopic camera technique

• Wieringa FP,
• Mastik F,
• Duncker D,
• Bogers A,
• van der Steen A

EuroInterv.2006;2:389-394

The Bedside Celution™ system for isolation of adipose derived regenerative cells

• Duckers H,
• Pinkernell K,
• Milstein AM,
• Hedrick MH

EuroInterv.2006;2:395-398

20 years of stenting: a patient's perspective

• Daemen J,
• van Mieghem CAG

EuroInterv.2006;2:399-401

Biodegradable drug eluting stents: invasive and non-invasive imaging

• Kukreja N,
• Otsuka M,
• van Mieghem CAG,
• Ligthart J,
• Sianos G,
• Serruys PW

EuroInterv.2006;2:403